
Loading, please wait...

Loading, please wait...

AIIMS Delhi recently revived its simultaneous Kidney-Pancreas Transplant program after a hiatus of 18 years. On April 14, 2026, a multidisciplinary team successfully performed this rare dual-organ surgery on a 30-year-old patient. The patient suffered from end-stage renal disease secondary to long-standing Type 1 diabetes. Consequently, this procedure offers a potential cure by addressing both conditions simultaneously. Furthermore, it can free patients from lifelong insulin dependence and dialysis.
A kidney-pancreas transplant is technically demanding because the pancreas is an extremely fragile organ. Furthermore, surgeons must manage complex vascular connections and drainage during the procedure. In this specific case, the patient faced additional risks due to cardiomyopathy and a reduced ejection fraction. However, the surgical team achieved stability within two-and-a-half hours. Since the surgery, the patient has maintained near-normal blood sugar levels with minimal insulin.
Pancreas transplantation requires a brain-dead cadaver donor as living donation is not feasible. The retrieval process often involves tight coordination across state lines. Specifically, this case utilized a green corridor between Rohtak and Delhi for rapid organ transport. This coordination remains vital for ensuring graft viability. Additionally, successful outcomes depend heavily on intensive post-operative monitoring and lifelong immunosuppression. Doctors describe this procedure as one of the most demanding organ transplants globally.
This successful revival signifies a new chapter for severe Type 1 diabetes patients in India. Currently, AIIMS reports a waiting list of several patients for similar dual-organ procedures. While only a few centers in India perform these transplants, the expertise at AIIMS provides hope for many. Successful grafts can eliminate the need for both dialysis and daily insulin injections. Therefore, this surgery significantly improves the quality of life for recipients.
Q1: Why is a simultaneous kidney-pancreas transplant performed?
It is primarily indicated for patients with Type 1 diabetes and end-stage renal disease. The procedure aims to resolve kidney failure and restore insulin independence simultaneously.
Q2: What are the main risks associated with this surgery?
The surgery is highly complex due to the sensitivity of the pancreas. Major risks include graft failure, pancreatitis, bleeding, and infections from required immunosuppressive medications.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


AIIMS Delhi successfully revives its simultaneous kidney-pancreas (SPK) transplant program after 18 years, performing a rare dual-organ procedure....
3 months ago

A new study reveals that lipid-related metabolic dysregulation, marked by elevated TG/HDL-C ratio and glymphatic changes, independently impacts survival in idiopathic normal pressure hydrocephalus.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

A meta-analysis of 13 propensity score-matched studies shows ViV-TAVR delivers lower early mortality and reduced bleeding compared to redo-SAVR for degenerated bioprosthetic aortic valves, though long-term hemodynamics warrant careful anatomical and patient-centered evaluation.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today